A scan test to help find pituitary tumors in Cushing disease
Original title: FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a special scan can show where a small pituitary tumor sits.
Who this trial is for. This trial is for people with Cushing disease caused by a pituitary tumor that makes a hormone called ACTH. It tests a scan called FET PET/CT to see how well it finds that tumor.
Where it stands. The trial has not reported results. The team is measuring how well the scan spots these tumors. They compare the scan with what surgeons find and what lab tests show in the tissue. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If the scan turns out to work well, it could help doctors find a tumor that is hard to see. Someone who fits this study could ask their care team about it.
What it doesn't mean: This does not mean the scan is proven. A trial is a test, not a treatment you can count on. Being in a trial is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, October 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.